While medications for opioid use disorder (MOUD) are an effective treatment, most patients with OUD don’t receive them, and prior authorization (PA) has been a barrier to access. Researchers looked at state policies trying to address this barrier, specifically for private health insurance, between 2015 and 2022. Some states adopted “full prohibitions” against PAs while others adopted “partial prohibitions” that allowed PA under some circumstances.

Read more: https://www.healthaffairs.org/doi/10.1377/hlthaff.2025.00191?asam.org